Combined administration of the GPVI-Fc fusion protein Revacept with low-dose thrombolysis in the treatment of stroke

Схожие документы

• The GPVI-Fc Fusion Protein Revacept Improves Cerebral Infarct Volume and Functional Outcome in Stroke
  по: Goebel, Silvia, et al.
  Опубликовано: (2013)
• The GPVI – Fc Fusion Protein Revacept Reduces Thrombus Formation and Improves Vascular Dysfunction in Atherosclerosis without Any Impact on Bleeding Times
  по: Ungerer, Martin, et al.
  Опубликовано: (2013)
• Review of Mouse Models of Graves’ Disease and Orbitopathy—Novel Treatment by Induction of Tolerance
  по: Ungerer, Martin, et al.
  Опубликовано: (2016)
• Differential Inhibition of Human Atherosclerotic Plaque–Induced Platelet Activation by Dimeric GPVI-Fc and Anti-GPVI Antibodies: Functional and Imaging Studies
  по: Jamasbi, Janina, et al.
  Опубликовано: (2015)
• Cross-Linking GPVI-Fc by Anti-Fc Antibodies Potentiates Its Inhibition of Atherosclerotic Plaque- and Collagen-Induced Platelet Activation
  по: Jamasbi, Janina, et al.
  Опубликовано: (2016)